Comparison of disease frequency between the urgent consultation group and the non-urgent consultation group
| Diagnosis | Non-urgent consultation group | Urgent consultation group | Total | P value* |
| n (%) | n (%) | n (%) | ||
| Upper respiratory tract infection (excluding influenza and COVID-19) | 100 (49.5) | 55 (29.9) | 155 (40.2) | |
| Influenza | 38 (18.8) | 36 (19.6) | 74 (19.2) | |
| Gastroenteritis/vomiting syndrome | 18 (8.9) | 31 (16.8) | 49 (12.7) | |
| Bronchitis | 8 (4.0) | 17 (9.2) | 25 (6.5) | |
| Rash | 8 (4.0) | 5 (2.7) | 13 (3.4) | |
| COVID-19 | 7 (3.5) | 6 (3.3) | 13 (3.4) | |
| Pharyngitis | 6 (3.0) | 5 (2.7) | 11 (2.8) | |
| Streptococcal infection | 5 (2.5) | 5 (2.8) | 10 (2.6) | |
| Asthma | 0 (0.0) | 5 (2.9) | 5 (1.3) | |
| Croup | 0 (0.0) | 4 (2.2) | 4 (1.0) | |
| Head injury | 3 (1.5) | 0 (0.0) | 3 (0.8) | |
| Otitis media | 0 (0.0) | 3 (1.6) | 3 (0.8) | |
| Constipation | 2 (1.0) | 3 (1.6) | 5 (1.3) | |
| Others | 7 (3.5) | 9 (4.8) | 16 (4.1) | |
| Total | 202 (100) | 184 (100) | 386 (100) | <0.0001 |
*P-value was generated using Fischer’s exact test. P value indicating statistically significant difference (p<0.05) is shown in bold.